Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy-Reference-Cited by-同舟云学术

Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy

Published:2020-11 Issue:3 Volume:108 Page:602-611
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Chou Wen-Chi,Chang Pei-Hung,Chen Ping-Tsung,Wang Hung-Ming,Yeh Kun-Yun,Lu Chang-Hsien,Hung Yu-Shin,Tung-Chieh Chang Joseph,Tsang Ngan-Ming,Ho Ya-Wen,Chen Shih-Ying,Lee Shu-Hui,Hung Chia-Yen,Wang Li-Jen,Liao Kuo-Chen,Lin Chung-Hao,Tang Woung-Ru,Lin Yung-Chang

Funder

Cancer Center of Chang Gung Memorial Hospital

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference48 articles.

1. State-of-the-art management of locally advanced head and neck cancer;Seiwert;Br J Cancer,2005

2. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous cell cancer of the head and neck: Long-term results of the TAX 324 randomised phase 3 trial;Lorch;Lancet Oncol,2011

3. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

4. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer;Zumsteg;Cancer,2017

5. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of pretreatment quality of life on tolerance and survival outcome in head and neck cancer patients undergoing definitive CCRT;Journal of the Formosan Medical Association;2024-09

2. Frailty is an independent factor for health-related quality of life in patients with head and neck cancer receiving definitive concurrent chemoradiotherapy;Supportive Care in Cancer;2024-01-15

3. Integrating Frailty Assessment to Enhance Care in Cancer Patients with Borderline Eastern Cooperative Oncology Group Performance Status;American Journal of Hospice and Palliative Medicine®;2024-01-05

4. Frailty and Cancer;Frailty;2024

5. Frailty assessment by two screening instruments in non-elderly patients with head and neck cancer;Oral Oncology;2023-12